PDF Print E-mail
General Plan
 GENERAL PROGRAM                      Wednesday                      Thursday


Access FREE OF CHARGE for ALL Seminars and Lectures, Biotech Trade Fair,
jobvector career day and Poster Presentations after obligatory REGISTRATION ONLINE


  GENERAL PROGRAM
 19th May - Wednesday
9:00 Opening ceremony 
 

Prof. Tadeusz Pietrucha, Bio-Tech Consulting, CEO

Julie Kjestrup, EuropaBio Healthcare Biotechnology Manager

Arnold Feher, head of Hungarian Biotechnology Association Strategic Committee
9:30  Roche: New Ways of Creative Partnership
 

Keynote speaker

Dr Valeria Povolotsky, Director, Global Business Development, Partnering

 Hoffmann-La Roche Inc.
10:00 Break    
10:45 Overview of biotechnology potential in CE
  Overview of Czech biotechnology
 Dr. Martin Buncek, member
 CzechBIO
Overview of the Biotechnology Sector in Hungary
 Monika Jankovics, project manager Hungarian Biotechnology Association
Opportunities for Lithuanian Biotech Related to Participation in the EU Baltic Sea Flagship project “Health Region” Prof. Leonas Grinius, representative Lithuanian Biotechnology association
Overview of Polish biotechnology
Prof.Tadeusz Pietrucha, CEO
Bio-Tech Consulting
12:30 Poster Session
13:00 Break    
13:30 Biotechnologies - from bench to market
  Cooperation with biotechnological companies in clinical trials - from the
CRO's view		 Dr. Kata Mazalin, General Manager
 Assign Group/GM Assign Hungary Kft.
Biotechnologies - different ways to achieve success Jerzy Pieczykolan, Project Manager Adamed Sp. z o.o.
14:15 Break    
14:45 Fund rising for  biotech enterprises
  Methods of financing operations and development in the pharmaceutical and biotechnology sectors - Part 1 Oliver Murphy, Partner,
Financial Advisory Services		 DELLOITE
Methods of financing operations and development in the pharmaceutical and biotechnology sectors - Part 2 Magdalena Jabłońska, Manager in Deloitte Grants & Incentives Team DELLOITE
Financing of biotech start-ups by the venture capital fund MCI.BioVentures Grzegorz Gromada, CEO MCI Bioventures
  Fund rising for biotech industry on New Connect – Mabion case study Artur Chabowski, CEO Acadia Artur Chabowski S.K.A.
16:15 Break    
16:30 Management of biotech enterprises
  Creating the right environment for biotech start-ups and SMEs: structures to support innovation and collaboration Julie Kjestrup, Healthcare Biotechnology Manager EuropaBio
  Keynote speaker
Solutions for success made in Lithuania Frank Sehlmeyer, Head of Business Development Group Fermentas UAB

 

20th May - Thursday
9:30
 Keynote speaker
  Adamed. From need to therapy. Maciej Adamkiewicz, CEO Adamed Sp. z o. o.
 
 
 		 Producing proteins in bioreactors with mammalian cells: From mgs to kgs, from academia to industry - a 25 year perspective Prof. Florian Wurm, CSO ExcellGene SA
R&D deals in biotech
Maximising your Return and Enforcing your Rights Patricia Barclay Bonaccord Ecosse Ltd
10:30 Break    
11:00 Overview of biotechnology potential in CE
  Overview of Latvian biotechnology Juris Vanags,
chairman of the board		 Latvian Biotechnology Association
Biotechnology in Ukraine: current state and future challenges Oleh V. Stasyk, PhD,
deputy director for science		 Institute of Cell biology,
National Academy of Sciences of Ukraine
Nano- and bio-technologies in therapeutics and environment bioengineering - romanian experience Prof.Rodica-Mariana Ion National Institute of Research and Development for Chemistry and Petrochemistry - ICECHIM, Bucharest
12:30 Poster Session  /  Hasco Lek Competition
13:00 Break    
 14:00 Biotech companies' issues - deals and support
  Start-Up Support and Cluster Development in Bavaria
Mathias Lamparter, PhD
Cluster manager
 Bio-M, Bavarian Biotech Cluster
Practical aspects of licensing transactions between universities, small Biomed companies and healthcare industry. Dr. Haim V. Levy INVESTIN Sp. z o.o.

How to create the IP portfolio and raise the value of the biotechnological start-up company – Read Gene S.A. case study

Rafał Witek, Partner

 WTS Patent Attorneys Witek, Sniezko & Partners  
Managing a biotech company in the emerging Krakow cluster – Selvita experiences Paweł Przewięźlikowski, CEO Selvita
15:30 Break    
16:00  BIOINNOVATIONS INC. - Top CE Biotech Innovative Companies - CONTEST CONCLUSION

Top CE companies - presentations
  Winners of the CONTEST


 

BioForum 2010 Media Partners:

-->